On Tuesday, Helius Medical Technologies Inc (NASDAQ: HSDT) was 37.15% up from the session before settling in for the closing price of $0.75. A 52-week range for HSDT has been $0.37 – $9.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -11.06% over the last five years. When this article was written, the company’s average yearly earnings per share was at 61.26%. With a float of $3.68 million, this company’s outstanding shares have now reached $3.73 million.
The firm has a total of 22 workers. Let’s measure their productivity. In terms of profitability, gross margin is -6.18%, operating margin of -2590.04%, and the pretax margin is -1764.74%.
Helius Medical Technologies Inc (HSDT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Helius Medical Technologies Inc stocks. The insider ownership of Helius Medical Technologies Inc is 1.42%, while institutional ownership is 2.17%.
Helius Medical Technologies Inc (HSDT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.92 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 61.26% per share during the next fiscal year.
Helius Medical Technologies Inc (NASDAQ: HSDT) Trading Performance Indicators
You can see what Helius Medical Technologies Inc (HSDT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.18, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -2.50 in one year’s time.
Technical Analysis of Helius Medical Technologies Inc (HSDT)
Analysing the last 5-days average volume posted by the [Helius Medical Technologies Inc, HSDT], we can find that recorded value of 28.04 million was better than the volume posted last year of 11.85 million. As of the previous 9 days, the stock’s Stochastic %D was 46.61%. Additionally, its Average True Range was 0.17.
During the past 100 days, Helius Medical Technologies Inc’s (HSDT) raw stochastic average was set at 53.55%, which indicates a significant increase from 42.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 168.80% in the past 14 days, which was lower than the 174.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6235, while its 200-day Moving Average is $1.2769. Now, the first resistance to watch is $1.4590. This is followed by the second major resistance level at $1.8879. The third major resistance level sits at $2.1759. If the price goes on to break the first support level at $0.7421, it is likely to go to the next support level at $0.4541. Now, if the price goes above the second support level, the third support stands at $0.0252.
Helius Medical Technologies Inc (NASDAQ: HSDT) Key Stats
There are 3,728K outstanding shares of the company, which has a market capitalization of 3.84 million. As of now, sales total 640 K while income totals -8,850 K. Its latest quarter income was 50 K while its last quarter net income were -3,690 K.
